Qvents
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Home
About Us
Contact Us
Expert Panel
Tags
Qvents
Warning Letters
483s
Recalls
Import Alerts
Quality Insights
Tags
Forums
Learning Resources
Upcoming Trainings
Training Archives
Guidelines
Pharma Jobs
Job Openings
Post a Job
Jobs posted by me
Users & Profiles
News
Login/Register
Individual
Company
Home
About Us
Contact Us
Expert Panel
Tags
Qvents
Warning Letters
483s
Recalls
Import Alerts
Quality Insights
Tags
Forums
Learning Resources
Upcoming Trainings
Training Archives
Guidelines
Pharma Jobs
Job Openings
Post a Job
Jobs posted by me
Users & Profiles
News
Login/Register
Reserve Samples / Retention Samples
Qvents
1 minute read
Guidelines
Home
Guidelines
Reserve Samples / Retention Samples
Updated on March 29, 2024
Home
Guidelines
Reserve Samples / Retention Samples
Updated on March 29, 2024
USFDA
:
211.170 Reserve samples
.
USFDA
– Retention of Bioavailability and Bioequivalence Testing Samples
USFDA
:
Handling and Retention of Bioavailability BA and Bioequivalence BE Testing Samples
EU GMP
Annex 19
:
Reference and Retention Samples
Share:
Facebook
LinkedIn
Twitter
Search Posts
Latest Posts
USFDA 483 Cites Piramal Pharma for Investigation Deficiencies, Procedural Non-Compliance
March 13, 2025
Contamination Control and Data Integrity Issues: Granules India Receives USFDA Warning Letter
March 7, 2025
Janssen’s Korea Vaccine Unit USFDA 483 Cites Aseptic Operations Not in Control
February 26, 2025
Facility Registration Violations, Refusal of Inspection: Jagsonpal Issued Warning letter
February 22, 2025
Purified Water System Qualification and Control: USFDA Expectations
February 11, 2025
